Science Explorer Back to mapMap
Discussion
Researcher · Stanford University · United States

Mark C. Genovese

Mark C. Genovese publishes mostly in Rheumatology, Immunology and Hematology, on topics such as Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments and Chronic Lymphocytic Leukemia Research.

ORCID 0000-0001-5294-4503 OpenAlex
World rank
#19,366
of 7,710,434 ranked researchers
Rank in United States
#7,025
of 1,627,098
Works
433
Citations
34k
Citations per work
78.2
h-index
89
i10-index 222Top 0.4% in Rheumatology
Mark C. Genovese

What does Mark C. Genovese research?

Mark C. Genovese's work is mostly in Medicine (65%), Immunology and Microbiology (11%).

Health Sciences: 283 works · 65.4% of their workMedicine: 283 works · 65.4% of their workRheumatology: 167 works · 38.6% of their workHematology: 40 works · 9.3% of their workGenetics: 39 works · 8.9% of their workRadiology, Nuclear Medicine and Imaging: 20 works · 4.7% of their workPathology and Forensic Medicine: 17 works · 3.9% of their workEverything else: 103 works · 23.7% of their workLife Sciences: 47 works · 10.9% of their workImmunology and Microbiology: 47 works · 10.9% of their workImmunology: 47 works · 10.9% of their workTHEIR WORKMark C. Genovese433works
Life Sciences11%Health Sciences65%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine28365.4%
  2. Everything else10323.7%
    1. Immunology and Microbiology4710.9%
  1. 1Rheumatology39% of their works
  2. 2Immunology11% of their works
  3. 3Hematology9% of their works
  4. 4Genetics9% of their works
  5. 5Radiology, Nuclear Medicine and Imaging5% of their works
  6. 6Pathology and Forensic Medicine4% of their works

Research topics

Which keywords describe Mark C. Genovese's research?

The keywords of their largest research topics: Autoantibodies, Inflammation, Rheumatoid Arthritis, Rituximab, Ankylosing Spondylitis, Spondyloarthritis, Monoclonal Antibodies and Chronic Lymphocytic Leukemia.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Autoantibodies3482 topics
  2. Inflammation2881 topic
  3. Rheumatoid Arthritis2881 topic
  4. Rituximab1322 topics
  5. Ankylosing Spondylitis1121 topic
  6. Spondyloarthritis1121 topic
  7. Monoclonal Antibodies1012 topics
  8. Chronic Lymphocytic Leukemia961 topic
  9. Genomic Aberrations961 topic
  10. Hemophagocytic Lymphohistiocytosis891 topic
  11. Juvenile Idiopathic Arthritis891 topic
  12. Antiphospholipid Syndrome601 topic
  13. Systemic Lupus Erythematosus601 topic
  14. Biosimilars521 topic
  15. Immunogenicity521 topic
  16. Fc Receptors491 topic
  17. Therapeutic Antibodies491 topic
  18. Classification361 topic
  19. Lymphoma361 topic

Where does Mark C. Genovese work?

Mark C. Genovese's main affiliation in the publication record is Stanford University, United States.

How many publications and citations does Mark C. Genovese have?

OpenAlex counts 433 works and 33,857 citations for Mark C. Genovese, an h-index of 89, ranking #19,366 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mark C. Genovese. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.